Self-poisoning of Mycobacterium tuberculosis by interrupting siderophore recycling

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 5, 2014, Pages 1945-1950

  Jones, Christopher M ^a   Wells, Ryan M ^a   Madduri, Ashoka V R ^b   Renfrow, Matthew B ^c   Ratledge, Colin ^d   Moody, D Branch ^b   Niederweis, Michael ^a  

^a University of Alabama at Birmingham   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF HULL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMYCOBACTIN; IRON; MYCOBACTIN; SIDEROPHORE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; BIOSYNTHESIS; GROWTH INHIBITION; HOMEOSTASIS; MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

BIOLOGICAL TRANSPORT; GENES, BACTERIAL; INTRACELLULAR SPACE; IRON; MODELS, BIOLOGICAL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXAZOLES; PROMOTER REGIONS, GENETIC; SALTS; SIDEROPHORES;

EID: 84893468680     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1311402111     Document Type: Article

References (47)

1. Miethke M, Marahiel MA (2007) Siderophore-based iron acquisition and pathogen control. Microbiol Mol Biol Rev 71(3):413-451.
2. Raymond KN, Dertz EA, Kim SS (2003) Enterobactin: An archetype for microbial iron transport. Proc Natl Acad Sci USA 100(7):3584-3588.
3. Loomis L, Raymond K (1991) Solution Equilibria of Enterobactin and Metal-Enterobactin Complexes. Inorg Chem 30:906-911.
4. Cooper SR, McArdle JV, Raymond KN (1978) Siderophore electrochemistry: Relation to intracellular iron release mechanism. Proc Natl Acad Sci USA 75(8):3551-3554.
5. Brickman TJ, McIntosh MA (1992) Overexpression and purification of ferric enterobactin esterase from Escherichia coli. Demonstration of enzymatic hydrolysis of enterobactin and its iron complex. J Biol Chem 267(17):12350-12355.
6. Miethke M, Hou J, Marahiel MA (2011) The siderophore-interacting protein YqjH acts as a ferric reductase in different iron assimilation pathways of Escherichia coli. Biochemistry 50(50):10951-10964.
7. Imperi F, Tiburzi F, Visca P (2009) Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad Sci USA 106(48):20440-20445.
8. Braun V, Brazel-Faisst C, Schneider R (1984) Growth Stimulation of Escherichia coli in serum by iron(III) aerobactin. Recycling of aerobactin. FEMS Microbiol Lett 21:99-103.
9. Hannauer M, Barda Y, Mislin GL, Shanzer A, Schalk IJ (2010) The ferrichrome uptake pathway in Pseudomonas aeruginosa involves an iron release mechanism with acylation of the siderophore and recycling of the modified desferrichrome. J Bacteriol 192(5):1212-1220.
10. Hartmann A, Braun V (1980) Iron transport in Escherichia coli: Uptake and modification of ferrichrome. J Bacteriol 143(1):246-255.
11. Emery T (1971) Role of ferrichrome as a ferric ionophore in Ustilago sphaerogena. Biochemistry 10(8):1483-1488.
12. Hider RC, Kong X (2010) Chemistry and biology of siderophores. Nat Prod Rep 27(5): 637-657.
13. Snow GA (1970) Mycobactins: Iron-chelating growth factors from mycobacteria. Bacteriol Rev 34(2):99-125.
14. Wells RM, et al. (2013) Discovery of a siderophore export system essential for virulence of Mycobacterium tuberculosis. PLoS Pathog 9(1):e1003120.
15. Jones CM, Niederweis M (2011) Mycobacterium tuberculosis can utilize heme as an iron source. J Bacteriol 193(7):1767-1770.
16. Tullius MV, et al. (2011) Discovery and characterization of a unique mycobacterial heme acquisition system. Proc Natl Acad Sci USA 108(12):5051-5056.
17. De Voss JJ, et al. (2000) The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages. Proc Natl Acad Sci USA 97(3):1252-1257.
18. Siegrist MS, et al. (2009) Mycobacterial Esx-3 is required for mycobactin-mediated iron acquisition. Proc Natl Acad Sci USA 106(44):18792-18797.
19. Madigan CA, et al. (2012) Lipidomic discovery of deoxysiderophores reveals a revised mycobactin biosynthesis pathway in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 109(4):1257-1262.
20. Jones CM, Niederweis M (2010) Role of porins in iron uptake by Mycobacterium smegmatis. J Bacteriol 192(24):6411-6417.
21. Sambandamurthy VK, et al. (2006) Mycobacterium tuberculosis DeltaRD1 DeltapanCD: A safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis. Vaccine 24(37-39): 6309-6320.
22. Ferreras JA, Ryu JS, Di Lello F, Tan DS, Quadri LE (2005) Small-molecule inhibition of siderophore biosynthesis in Mycobacterium tuberculosis and Yersinia pestis. Nat Chem Biol 1(1):29-32.
23. Qiao C, et al. (2007) 5'-O-[(N-acyl)sulfamoyl]adenosines as antitubercular agents that inhibit MbtA: An adenylation enzyme required for siderophore biosynthesis of the mycobactins. J Med Chem 50(24):6080-6094.
24. Layre E, et al. (2011) A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis. Chem Biol 18(12):1537-1549.
25. Hannauer M, Yeterian E, Martin LW, Lamont IL, Schalk IJ (2010) An efflux pump is involved in secretion of newly synthesized siderophore by Pseudomonas aeruginosa. FEBS Lett 584(23):4751-4755.
26. Deshayes C, et al. (2010) MmpS4 promotes glycopeptidolipids biosynthesis and export in Mycobacterium smegmatis. Mol Microbiol 78(4):989-1003.
27. Ratledge C (2004) Iron, mycobacteria and tuberculosis. Tuberculosis (Edinb) 84(1-2): 110-130.
28. Brickman TJ, Armstrong SK (2005) Bordetella AlcS transporter functions in alcaligin siderophore export and is central to inducer sensing in positive regulation of alcaligin system gene expression. J Bacteriol 187(11):3650-3661.
29. Rodriguez GM, Smith I (2006) Identification of an ABC transporter required for iron acquisition and virulence in Mycobacterium tuberculosis. J Bacteriol 188(2):424-430.
30. Ryndak MB, Wang S, Smith I, Rodriguez GM (2010) The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol 192(3): 861-869.
31. Brown KA, Ratledge C (1975) Iron transport in Mycobacterium smegmatis: Ferrimycobactin reductase (nad(p)h:ferrimycobactin oxidoreductase), the enzyme releasing iron from its carrier. FEBS Lett 53(2):262-266.
32. Gobin J, Horwitz MA (1996) Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med 183(4):1527-1532.
33. Schaible UE, Kaufmann SH (2004) Iron and microbial infection. Nat Rev Microbiol 2(12):946-953.
34. Ojha AK, et al. (2008) Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69(1):164-174.
35. Crosa JH, Walsh CT (2002) Genetics and assembly line enzymology of siderophore biosynthesis in bacteria. Microbiol Mol Biol Rev 66(2):223-249.
36. Russell DG (2011) Mycobacterium tuberculosis and the intimate discourse of a chronic infection. Immunol Rev 240(1):252-268.
37. Canetti G (1965) Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 92(5):687-703.
38. Hingley-Wilson SM, Sambandamurthy VK, Jacobs WR, Jr. (2003) Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis. Nat Immunol 4(10):949-955.
39. Lambrecht RS, Collins MT (1993) Inability to detect mycobactin in mycobacteriainfected tissues suggests an alternative iron acquisition mechanism by mycobacteria in vivo. Microb Pathog 14(3):229-238.
40. Collins L, Franzblau SG (1997) Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Agents Chemother 41(5):1004-1009.
41. Efremov RG, Baradaran R, Sazanov LA (2010) The architecture of respiratory complex I. Nature 465(7297):441-445.
42. Andrews NC (2003) Disorders of iron metabolism. Blood: Principles and Practice of Hematology, ed Handin RI Lux SE, Stossel TP (Lippincott Williams and Wilkins, Philadelphia, PA), 2nd Ed, pp 1401-1433.
43. Reddy PV, et al. (2013) Disruption of mycobactin biosynthesis leads to attenuation of Mycobacterium tuberculosis for growth and virulence. J Infect Dis 208(8):1255-1265.
44. Jones CM, Niederweis M (2013) Organ pathology in the absence of bacteria? J Infect Dis, in press.
45. Chavadi SS, et al. (2011) Mutational and phylogenetic analyses of the mycobacterial mbt gene cluster. J Bacteriol 193(21):5905-5913.
46. Gobin J, et al. (1995) Iron acquisition by Mycobacterium tuberculosis: Isolation and characterization of a family of iron-binding exochelins. Proc Natl Acad Sci USA 92(11): 5189-5193.
47. Serafini A, Boldrin F, Palù G, Manganelli R (2009) Characterization of a Mycobacterium tuberculosis ESX-3 conditional mutant: Essentiality and rescue by iron and zinc. J Bacteriol 191(20):6340-6344.